Current management of primary sclerosing cholangitis in pediatric patients

Pediatric Drugs

Volumn 13, Issue 2, 2011, Pages 87-95

  Ibrahim, Samar H ^a   Lindor, Keith D ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ALPHA TOCOPHEROL; AMINOGLYCOSIDE; ANTIBIOTIC AGENT; ANTIFIBROTIC AGENT; ANTIHISTAMINIC AGENT; AZITHROMYCIN; CEPHALOSPORIN; COLESEVELAM; COLESTIPOL; COLESTYRAMINE; COTRIMOXAZOLE; IMMUNOSUPPRESSIVE AGENT; METRONIDAZOLE; MINOCYCLINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NALMEFENE; NALOXONE; NALTREXONE; NEOMYCIN; OPIATE ANTAGONIST; PHENOBARBITAL; PIRFENIDONE; PROPRANOLOL; RETINOL; RIFAMPICIN; TACROLIMUS; URSODEOXYCHOLIC ACID; VANCOMYCIN;

AMINOTRANSFERASE BLOOD LEVEL; BILIARY TRACT SURGERY; BLEEDING; CHOLANGITIS; DISEASE MARKER; DRUG DOSE INCREASE; DRUG ELIMINATION; DRUG HALF LIFE; DRUG HYPERSENSITIVITY; DRUG MEGADOSE; DRUG SAFETY; DRUG WITHDRAWAL; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENDOSCOPIC SURGERY; HUMAN; LABORATORY DIAGNOSIS; LIVER HISTOLOGY; LIVER TRANSPLANTATION; LOADING DRUG DOSE; PORTAL HYPERTENSION; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PRURITUS; RADIODIAGNOSIS; RECURRENT DISEASE; REVIEW; UNSPECIFIED SIDE EFFECT; VITAMIN SUPPLEMENTATION;

CHILD; CHOLANGITIS, SCLEROSING; HUMANS;

EID: 79952178724     PISSN: 11745878     EISSN: 11792019     Source Type: Journal    
DOI: 10.2165/11586500-000000000-00000     Document Type: Review

References (78)

1. Angulo P, Lindor KD. Primary sclerosing cholangitis. Hepatology 1999 Jul; 30 (1): 325-32 (Pubitemid 29300604)
2. Gregorio GV, Portmann B, Karani J, et al. Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study. Hepatology 2001 Mar; 33 (3): 544-53 (Pubitemid 32185215)
3. Debray D, Pariente D, Urvoas E, et al. Sclerosing cholangitis in children. J Pediatr 1994 Jan; 124 (1): 49-56 (Pubitemid 24027286)
4. Feldstein AE, Perrault J, El-Youssif M, et al. Primary sclerosing cholangitis in children: a long-term follow-up study. Hepatology 2003 Jul; 38 (1): 210-7 (Pubitemid 36775813)
5. el-Shabrawi M, Wilkinson ML, Portmann B, et al. Primary sclerosing cholangitis in childhood. Gastroenterology 1987 May; 92 (5 Pt 1: 1226-35. (Pubitemid 17055913)
6. Wilschanski M, Chait P, Wade JA, et al. Primary sclerosing cholangitis in 32 children: clinical, laboratory, and radiographic features, with survival analysis. Hepatology 1995 Nov; 22 (5): 1415-22
7. Miloh T, Arnon R, Shneider B, et al. A retrospective single-center review of primary sclerosing cholangitis in children. Clin Gastroenterol Hepatol 2009 Feb; 7 (2): 239-45
8. Lindor KD. Ursodiol for primary sclerosing cholangitis. Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Acid Study Group. N Engl J Med 1997 Mar 6; 336 (10): 691-5
9. Olsson R, Boberg KM, de Muckadell OS, et al. High-dose ursodeoxycholic acid in primary sclerosing cholangitis: a 5-year multicenter, randomized, controlled study. Gastroenterology 2005 Nov; 129 (5): 1464-72 (Pubitemid 41597389)
10. Lindor KD, Kowdley KV, Luketic VA, et al. High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis. Hepatology 2009 Sep; 50 (3): 808-14
11. Chapman R, Fevery J, Kalloo A, et al. Diagnosis and management of primary sclerosing cholangitis. Hepatology 2010 Feb; 51 (2): 660-78
12. Graziadei IW, Wiesner RH, Batts KP, et al. Recurrence of primary sclerosing cholangitis following liver transplantation. Hepatology 1999 Apr; 29 (4): 1050-6 (Pubitemid 29168735)
13. Batres LA, Russo P, Mathews M, et al. Primary sclerosing cholangitis in children: a histologic follow-up study. Pediatr Dev Pathol 2005 Sep-Oct; 8 (5): 568-76 (Pubitemid 41641603)
14. Bambha K, Kim WR, Talwalkar J, et al. Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community. Gastroenterology 2003 Nov; 125 (5): 1364-9 (Pubitemid 37409756)
15. Kingham JG, Kochar N, Gravenor MB. Incidence, clinical patterns, and outcomes of primary sclerosing cholangitis in South Wales, United Kingdom. Gastroenterology 2004 Jun; 126 (7): 1929-30 (Pubitemid 38736362)
16. Card TR, Solaymani-Dodaran M, West J. Incidence and mortality of primary sclerosing cholangitis in the UK: a population-based cohort study. J Hepatol 2008 Jun; 48 (6): 939-44
17. Kaplan GG, Laupland KB, Butzner D, et al. The burden of large and small duct primary sclerosing cholangitis in adults and children: a population-based analysis. Am J Gastroenterol 2007 May; 102 (5): 1042-9 (Pubitemid 46705300)
18. Floreani A, Zancan L, Melis A, et al. Primary sclerosing cholangitis (PSC): clinical, laboratory and survival analysis in children and adults. Liver 1999 Jun; 19 (3): 228-33 (Pubitemid 29261590)
19. Hov JR, Boberg KM, Karlsen TH. Autoantibodies in primary sclerosing cholangitis. World J Gastroenterol 2008 Jun 28; 14 (24): 3781-91
20. Dienes HP, Lohse AW, Gerken G, et al. Bile duct epithelia as target cells in primary biliary cirrhosis and primary sclerosing cholangitis. Virchows Arch 1997 Aug; 431 (2): 119-24 (Pubitemid 27393842)
21. Davies YK, Cox KM, Abdullah BA, et al. Long-term treatment of primary sclerosing cholangitis in children with oral vancomycin: an immunomodulating antibiotic. J Pediatr Gastroenterol Nutr 2008 Jul; 47 (1): 61-7
22. Mason AL, Xu L, Guo L, et al. Detection of retroviral antibodies in primary biliary cirrhosis and other idiopathic biliary disorders. Lancet 1998 May 30; 351 (9116): 1620-4 (Pubitemid 28252178)
23. Rosenthal P. Sclerosing cholangitis. In:WalkerWA,KleinmanRE, ShermanPM, et al., editors. Pediatric gastrointestinal disease. Hamilton (ON): BC Decker, 2004: 1142-3
24. Roberts EA. Primary sclerosing cholangitis in children. J Gastroenterol Hepatol 1999 Jun; 14 (6): 588-93 (Pubitemid 29281883)
25. Jaffe R. Liver involvement in the histiocytic disorders of childhood. Pediatr Dev Pathol 2004 May-Jun; 7 (3): 214-25 (Pubitemid 38859149)
26. Rodrigues F, Davies EG, Harrison P, et al. Liver disease in children with primary immunodeficiencies. J Pediatr 2004 Sep; 145 (3): 333-9 (Pubitemid 39165681)
27. Durieu I, Pellet O, Simonot L, et al. Sclerosing cholangitis in adults with cystic fibrosis: a magnetic resonance cholangiographic prospective study. J Hepatol 1999 Jun; 30 (6): 1052-6 (Pubitemid 29278749)
28. Ebbeson RL, Schreiber RA. Diagnosing autoimmune hepatitis in children: is the International Autoimmune Hepatitis Group scoring system useful? Clin Gastroenterol Hepatol 2004 Oct; 2 (10): 935-40 (Pubitemid 39335801)
29. Suchy FJ, Sokol RJ, Ballisteri WF. Liver diseases in children. 3rd ed. Cambridge (NY): Cambridge University Press, 2007
30. MacCarty RL, LaRusso NF, Wiesner RH, et al. Primary sclerosing cholangitis: findings on cholangiography and pancreatography. Radiology 1983 Oct; 149 (1): 39-44 (Pubitemid 13006800)
31. Chavhan GB, Babyn PS, Manson D, et al. Pediatric MR cholangiopancreatography: principles, technique, and clinical applications. Radiographics 2008 Nov-Dec; 28 (7): 1951-62
32. LaRusso NF, Shneider BL, Black D, et al. Primary sclerosing cholangitis: summary of a workshop. Hepatology 2006 Sep; 44 (3): 746-64 (Pubitemid 44433732)
33. Cullen SN, Chapman RW. The medical management of primary sclerosing cholangitis. Semin Liver Dis 2006 Feb; 26 (1): 52-61 (Pubitemid 43320727)
34. Galle PR, Theilmann L, Raedsch R, et al. Ursodeoxycholate reduces hepatotoxicity of bile salts in primary human hepatocytes. Hepatology 1990 Sep; 12 (3 Pt 1): 486-91 (Pubitemid 20382016)
35. Angulo P. Use of ursodeoxycholic acid in patients with liver disease. Curr Gastroenterol Rep 2002 Feb; 4 (1): 37-44
36. Balistreri WF. Bile acid therapy in pediatric hepatobiliary disease: the role of ursodeoxycholic acid. J Pediatr Gastroenterol Nutr 1997 May; 24 (5): 573-89 (Pubitemid 27216877)
37. Beuers U, Spengler U, Kruis W, et al. Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial. Hepatology 1992 Sep; 16 (3): 707-14
38. Gilger MA, Gann ME, Opekun AR, et al. Efficacy of ursodeoxycholic acid in the treatment of primary sclerosing cholangitis in children. J Pediatr Gastroenterol Nutr 2000 Aug; 31 (2): 136-41 (Pubitemid 30618302)
39. Chen W, Gluud C. Bile acids for primary sclerosing cholangitis. Cochrane Database Syst Rev 2003; (2): CD003626
40. Elfaki DA, Lindor KD. Antibiotics for the treatment of primary sclerosing cholangitis. Am J Ther. Epub 2009 Sep 15
41. Silveira MG, Torok NJ, Gossard AA, et al. Minocycline in the treatment of patients with primary sclerosing cholangitis: results of a pilot study. Am J Gastroenterol 2009 Jan; 104 (1): 83-8
42. Farkkila M, Karvonen AL, Nurmi H, et al. Metronidazole and ursodeoxycholic acid for primary sclerosing cholangitis: a randomized placebo-controlled trial. Hepatology 2004 Dec; 40 (6): 1379-86 (Pubitemid 39657012)
43. Boner AL, Peroni D, Bodini A, et al. Azithromycin may reduce cholestasis in primary sclerosing cholangitis: a case report and serendipitous observation. Int J Immunopathol Pharmacol 2007 Oct-Dec; 20 (4): 847-9
44. Talwalkar JA, Gossard AA, Keach JC, et al. Tacrolimus for the treatment of primary sclerosing cholangitis. Liver Int 2007 May; 27 (4): 451-3 (Pubitemid 46534566)
45. Talwalkar JA, Angulo P, Keach JC, et al. Mycophenolate mofetil for the treatment of primary sclerosing cholangitis. Am J Gastroenterol 2005 Feb; 100 (2): 308-12 (Pubitemid 40314514)
46. Lindor KD, Jorgensen RA, Anderson ML, et al. Ursodeoxycholic acid and methotrexate for primary sclerosing cholangitis: a pilot study. Am J Gastroenterol 1996 Mar; 91 (3): 511-5 (Pubitemid 26083555)
47. Angulo P, Batts KP, Jorgensen RA, et al. Oral budesonide in the treatment of primary sclerosing cholangitis. Am J Gastroenterol 2000 Sep; 95 (9): 2333-7
48. Chen W, Gluud C. Glucocorticosteroids for primary sclerosing cholangitis. Cochrane Database Syst Rev 2004; (3): CD004036
49. Epstein MP, Kaplan MM. A pilot study of etanercept in the treatment of primary sclerosing cholangitis. Dig Dis Sci 2004 Jan; 49 (1): 1-4 (Pubitemid 38183736)
50. Bharucha AE, Jorgensen R, Lichtman SN, et al. A pilot study of pentoxifylline for the treatment of primary sclerosing cholangitis. Am J Gastroenterol 2000 Sep; 95 (9): 2338-42
51. Angulo P, MacCarty RL, Sylvestre PB, et al. Pirfenidone in the treatment of primary sclerosing cholangitis. Dig Dis Sci 2002 Jan; 47 (1): 157-61 (Pubitemid 34075033)
52. Ozsoylu S, Kocak N, Yuce A. Propranolol therapy for portal hypertension in children. J Pediatr 1985 Feb; 106 (2): 317-21 (Pubitemid 15130091)
53. Shashidhar H, Langhans N, Grand RJ. Propranolol in prevention of portal hypertensive hemorrhage in children: a pilot study. J Pediatr Gastroenterol Nutr 1999 Jul; 29 (1): 12-7 (Pubitemid 30345821)
54. Shneider B, Emre S, Groszmann R, et al. Expert pediatric opinion on the report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. Pediatr Transplant 2006 Dec; 10 (8): 893-907 (Pubitemid 44683633)
55. Yerushalmi B, Sokol RJ, Narkewicz MR, et al. Use of rifampin for severe pruritus in children with chronic cholestasis. J Pediatr Gastroenterol Nutr 1999 Oct; 29 (4): 442-7 (Pubitemid 30346365)
56. Cies JJ, Giamalis JN. Treatment of cholestatic pruritus in children. Am J Health Syst Pharm 2007 Jun 1; 64 (11): 1157-62 (Pubitemid 46849305)
57. Sprecher DL, Daniels SR. Rational approach to pharmacologic reduction of cholesterol levels in children. J Pediatr 1996 Jul; 129 (1): 4-7 (Pubitemid 26277241)
58. Kremer AE, Beuers U, Oude-Elferink RP, et al. Pathogenesis and treatment of pruritus in cholestasis. Drugs 2008; 68 (15): 2163-82
59. Rust C, Sauter GH, Oswald M, et al. Effect of cholestyramine on bile acid pattern and synthesis during administration of ursodeoxycholic acid in man. Eur J Clin Invest 2000 Feb; 30 (2): 135-9 (Pubitemid 30079571)
60. Mela M, Mancuso A, Burroughs AK. Review article: pruritus in cholestatic and other liver diseases. Aliment Pharmacol Ther 2003 Apr 1; 17 (7): 857-70 (Pubitemid 36459598)
61. Bergasa NV, Schmitt JM, Talbot TL, et al. Open-label trial of oral nalmefene therapy for the pruritus of cholestasis. Hepatology 1998; 27: 679-84 (Pubitemid 28103542)
62. Chang Y, Golkar L. The use of naltrexone in the management of severe generalized pruritus in biliary atresia: report of a case. Pediatr Dermatol 2008; 25 (3): 403-4 (Pubitemid 351813977)
63. McRae CA, Prince MI, Hudson M, et al. Pain as a complication of use of opiate antagonists for symptom control in cholestasis. Gastroenterology 2003; 125: 591-6 (Pubitemid 36929440)
64. Narkewicz MR, Smith D, Gregory C, et al. Effect of ursodeoxycholic acid therapy on hepatic function in children with intrahepatic cholestatic liver disease. J Pediatr Gastroenterol Nutr 1998 Jan; 26 (1): 49-55 (Pubitemid 28023836)
65. Dinler G, Kocak N, Yuce A, et al. Ursodeoxycholic acid therapy in children with cholestatic liver disease. Turk J Pediatrics 1999 Jan-Mar; 41 (1): 91-8 (Pubitemid 29104440)
66. StiehlA, Thaler MM, Admirand WH. The effects of phenobarbital on bile salts and bilirubin in patients with intrahepatic and extrahepatic cholestasis. N Engl J Med 1972 Apr 20; 286 (16): 858-61
67. Miguet JP, Mavier P, Soussy CJ, et al. Induction of hepatic microsomal enzymes after brief administration of rifampicin in man. Gastroenterology 1977 May; 72 (5 Pt 1): 924-6 (Pubitemid 8093906)
68. Wietholtz H, Marschall HU, Sjovall J, et al. Stimulation of bile acid 6 alphahydroxylation by rifampin. J Hepatol 1996 Jun; 24 (6): 713-8 (Pubitemid 26226668)
69. Browning J, Combes B, Mayo MJ. Long-term efficacy of sertraline as a treatment for cholestatic pruritus in patients with primary biliary cirrhosis. Am J Gastroenterol 2003 Dec; 98 (12): 2736-41 (Pubitemid 38020117)
70. Zylicz Z, Krajnik M, Sorge AA, et al. Paroxetine in the treatment of severe nondermatological pruritus: a randomized, controlled trial. J Pain Symptom Manage 2003 Dec; 26 (6): 1105-12 (Pubitemid 37488018)
71. Bu LN, Chen HL, Chang CJ, et al. Prophylactic oral antibiotics in prevention of recurrent cholangitis after theKasai portoenterostomy. J Pediatr Surg 2003 Apr; 38 (4): 590-3
72. Lee JG, Schutz SM, England RE, et al. Endoscopic therapy of sclerosing cholangitis. Hepatology 1995 Mar; 21 (3): 661-7
73. Wagner S, Gebel M, Meier P, et al. Endoscopic management of biliary tract strictures in primary sclerosing cholangitis. Endoscopy 1996 Sep; 28 (7): 546-51 (Pubitemid 26385589)
74. Stoker J, Lameris JS, Robben SG, et al. Primary sclerosing cholangitis in a child treated by nonsurgical balloon dilatation and stenting. J Pediatr Gastroenterol Nutr 1993 Oct; 17 (3): 303-6 (Pubitemid 23314065)
75. Martin FM, Rossi RL, Nugent FW, et al. Surgical aspects of sclerosing cholangitis: results in 178 patients. Ann Surg 1990 Oct; 212 (4): 551-6; discussion 556-8
76. Ismail T, Angrisani L, Powell JE, et al. Primary sclerosing cholangitis: surgical options, prognostic variables and outcome. Br J Surgery 1991 May; 78 (5): 564-7
77. McDiarmid SV, Anand R. Studies of Pediatric Liver Transplantation (SPLIT): a summary of the 2003 annual report. Clin Transpl 2003; 119-30
78. Vera A, Moledina S, Gunson B, et al. Risk factors for recurrence of primary sclerosing cholangitis of liver allograft. Lancet 2002 Dec 14; 360 (9349): 1943-4 (Pubitemid 35472138)